Dionne Lomax, a Member of the Antitrust Section of Mintz, Cohn, Ferris, Glovsky and Popeo, P.C., presented at the American Health Lawyers Association’s (AHLA) annual meeting. The conference took place June 29-July 1 at the Marriot Marquis in Washington, DC.

Ms. Lomax’s session was entitled, “Antitrust and Provider Mergers and Affiliations: Competition vs More Affordable Care?”

The AHLA is the nation's largest, nonpartisan, 501(c)(3) educational organization devoted to legal issues in the health care field. The Association’s mission is to provide a collegial forum for interaction and information exchange to enable its members to serve their clients more effectively; to produce the highest quality non-partisan educational programs, products, and services concerning health law issues; and to serve as a public resource on selected healthcare legal issues. The AHLA Annual Meeting provides a forum for networking and interaction with colleagues, friends, and family as well as an outstanding educational event. Every year, the Annual Meeting offers an array of health law topics that will appeal to anyone practicing in this area.

Ms. Lomax’s antitrust and trade regulation practice includes counseling and representation in connection with merger and nonmerger related activities, litigation, and matters before the US Department of Justice (DOJ) and the Federal Trade Commission (FTC). She has been involved in antitrust matters spanning a broad range of industries, but has particularly deep experience in the health care and energy sectors. In the health care industry, Ms. Lomax has represented large health systems, major medical associations, large multi-specialty physician groups, pharmaceutical companies, and medical device manufacturers in connection with mergers and acquisitions, joint ventures, and other commercial arrangements. She has counseled various clients in responding to antitrust investigations conducted by the DOJ, FTC, and various state antitrust agencies. Ms. Lomax previously served as a trial attorney at the U.S. Department of Justice Antitrust Division Health Care Task Force Section.